-
★
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
(Hinzugefügt: 06.08.2021 um 11:23 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMoa2103417
-
★
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
(Hinzugefügt: 06.08.2021 um 11:22 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMoa2105911
-
★
ASH Guidelines on Use of Anticoagulation in Patients with COVID-19
(Hinzugefügt: 25.11.2020 um 09:28 Uhr)
https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/ash-guidelines-on-use-of-anticoagulation-in-patients-with-covid-19
-
★
Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
(Hinzugefügt: 24.11.2020 um 20:41 Uhr)
https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-03375-7
-
★
Enoxaparin/ Heparin
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.medrxiv.org/content/10.1101/2020.10.06.20208025v1
-
Effectiveness and safety of extended thromboprophylaxis in post-discharge patients with COVID-19: A systematic review and meta-analysis
(Hinzugefügt: 06.12.2022 um 16:10 Uhr)
https://www.thrombosisresearch.com/article/S0049-3848(22)00469-8/fulltext
-
Hypercoagulability in COVID-19 and post-COVID patients - characteristics and current treatment guidelines
(Hinzugefügt: 29.11.2022 um 16:16 Uhr)
https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-21/hypercoagulability-in-covid-19-and-post-covid-patients-characteristics-and-cur
-
Medikamentöse Thrombose-Prophylaxe bei ambulanten COVID-19-Patienten
(Hinzugefügt: 09.05.2022 um 08:43 Uhr)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075715/
-
Association of Early Aspirin Use With In-Hospital Mortality in Patients With Moderate COVID-19
(Hinzugefügt: 26.03.2022 um 11:22 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2790439
-
Extending Rivaroxaban After COVID-19 Hospitalization
(Hinzugefügt: 16.02.2022 um 13:57 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2788849
-
D-Dimer
(Hinzugefügt: 10.01.2022 um 12:23 Uhr)
https://de.wikipedia.org/wiki/D-Dimer
-
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial
(Hinzugefügt: 21.12.2021 um 12:45 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02392-8/fulltext
-
ASH Guidelines on Use of Anticoagulation in Patients with COVID-19
(Hinzugefügt: 21.12.2021 um 12:35 Uhr)
https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/ash-guidelines-on-use-of-anticoagulation-in-patients-with-covid-19
-
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
(Hinzugefügt: 21.12.2021 um 12:29 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01825-0/fulltext
-
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
(Hinzugefügt: 20.12.2021 um 19:37 Uhr)
https://ashpublications.org/bloodadvances/article/5/3/872/475154/American-Society-of-Hematology-2021-guidelines-on
-
Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials
(Hinzugefügt: 13.12.2021 um 10:00 Uhr)
https://pubmed.ncbi.nlm.nih.gov/34830648/
-
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01825-0/fulltext
(Hinzugefügt: 19.11.2021 um 21:05 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01825-0/fulltext
-
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study
(Hinzugefügt: 15.11.2021 um 07:24 Uhr)
https://academic.oup.com/cardiovascres/advance-article/doi/10.1093/cvr/cvab308/6381563
-
Strategien zur Antikoagulation bei COVID-19
(Hinzugefügt: 15.11.2021 um 07:22 Uhr)
https://www.aerzteblatt.de/nachrichten/129055/Strategien-zur-Antikoagulation-bei-COVID-19
-
Strategien zur Antikoagulation bei COVID-19
(Hinzugefügt: 14.11.2021 um 15:03 Uhr)
https://www.aerzteblatt.de/nachrichten/129055/Strategien-zur-Antikoagulation-bei-COVID-19
-
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19
(Hinzugefügt: 18.10.2021 um 09:45 Uhr)
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2785004
-
Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19
(Hinzugefügt: 18.10.2021 um 09:44 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2785218
-
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19
(Hinzugefügt: 12.10.2021 um 10:53 Uhr)
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2785004
-
Anticoagulant Therapy in Patients Hospitalized With COVID-19
(Hinzugefügt: 12.10.2021 um 10:53 Uhr)
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2785005
-
Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients
(Hinzugefügt: 05.10.2021 um 09:36 Uhr)
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00419-3/fulltext
-
NEJM: Anticoagulants help moderately ill COVID-19 patients
(Hinzugefügt: 24.08.2021 um 16:14 Uhr)
https://www.utsouthwestern.edu/newsroom/articles/year-2021/anticoagulants-help-ill-covid-19-patients.html
-
COVID-19: Frühe Antikoagulation zeigt Wirkung bei mittelschweren Erkrankungen
(Hinzugefügt: 17.07.2021 um 13:23 Uhr)
https://www.aerzteblatt.de/nachrichten/125578/COVID-19-Fruehe-Antikoagulation-zeigt-Wirkung-bei-mittelschweren-Erkrankungen
-
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
(Hinzugefügt: 09.06.2021 um 19:25 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01203-4/fulltext
-
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
(Hinzugefügt: 06.06.2021 um 17:15 Uhr)
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01203-4/fulltext
-
Decreased In-Hospital Mortality Associated with Aspirin Administration in Hospitalized Patients Due to Severe COVID-19.
(Hinzugefügt: 05.05.2021 um 10:29 Uhr)
https://europepmc.org/article/med/33913549
-
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
(Hinzugefügt: 29.04.2021 um 07:23 Uhr)
https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00105-8/fulltext
-
Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis
(Hinzugefügt: 11.04.2021 um 06:37 Uhr)
https://link.springer.com/article/10.1007/s11239-021-02436-0
-
Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019
(Hinzugefügt: 30.03.2021 um 08:21 Uhr)
https://journals.lww.com/anesthesia-analgesia/fulltext/2021/04000/aspirin_use_is_associated_with_decreased.2.aspx
-
Implementation and Evaluation of Virtual Anticoagulation Clinic Care to Provide Incessant Care During COVID-19 Times in an Indian Tertiary Care Teaching Hospital
(Hinzugefügt: 29.03.2021 um 06:50 Uhr)
https://www.frontiersin.org/articles/10.3389/fcvm.2021.648265/full
-
Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID‐19
(Hinzugefügt: 24.03.2021 um 10:07 Uhr)
https://onlinelibrary.wiley.com/doi/10.1111/bjh.16927
-
Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection
(Hinzugefügt: 24.03.2021 um 10:06 Uhr)
https://www.springermedizin.de/covid-19/argatroban-for-therapeutic-anticoagulation-for-heparin-resistanc/18309172
-
Role of Combining Anticoagulant and Antiplatelet Agents in COVID-19 Treatment: A Rapid Review
(Hinzugefügt: 23.03.2021 um 09:58 Uhr)
https://www.medrxiv.org/content/10.1101/2021.03.21.21253754v1
-
Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19
(Hinzugefügt: 20.03.2021 um 18:42 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2777828
-
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
(Hinzugefügt: 18.03.2021 um 21:46 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2777829
-
COVID-19 ARTICLES: ORIGINAL CLINICAL RESEARCH REPORT Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019
(Hinzugefügt: 18.03.2021 um 06:00 Uhr)
https://journals.lww.com/anesthesia-analgesia/fulltext/2021/04000/aspirin_use_is_associated_with_decreased.2.aspx
-
Thrombosegefahr bei schwer kranken Covid-19-Patienten: Störer im Gerinnungssystem gefunden
(Hinzugefügt: 15.03.2021 um 19:35 Uhr)
https://www.lifepr.de/pressemitteilung/deutsche-herzstiftung-ev-frankfurt-am-main/Thrombosegefahr-bei-schwer-kranken-Covid-19-Patienten-Stoerer-im-Gerinnungssystem-gefunden/boxid/839297
-
Aspirin may protect against COVID-19, Israeli research finds
(Hinzugefügt: 14.03.2021 um 06:12 Uhr)
https://www.timesofisrael.com/aspirin-may-protect-against-covid-19-israeli-research-finds/
-
Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
(Hinzugefügt: 14.03.2021 um 05:54 Uhr)
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00054-7/fulltext
-
COVID-19: Deutsche Fachgesellschaften geben zurückhaltende Therapieempfehlungen für stationäre Patienten ab
(Hinzugefügt: 24.02.2021 um 16:53 Uhr)
https://www.aerzteblatt.de/nachrichten/121450/COVID-19-Deutsche-Fachgesellschaften-geben-zurueckhaltende-Therapieempfehlungen-fuer-stationaere-Patienten-ab
-
COVID-19: US-Kliniken machen gute Erfahrungen mit prophylaktischer Antikoagulation
(Hinzugefügt: 15.02.2021 um 09:02 Uhr)
https://www.aerzteblatt.de/nachrichten/121135/COVID-19-US-Kliniken-machen-gute-Erfahrungen-mit-prophylaktischer-Antikoagulation
-
Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients
(Hinzugefügt: 07.02.2021 um 15:54 Uhr)
https://www.nih.gov/news-events/news-releases/full-dose-blood-thinners-decreased-need-life-support-improved-outcome-hospitalized-covid-19-patients
-
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19
(Hinzugefügt: 02.02.2021 um 20:00 Uhr)
https://www.acpjournals.org/doi/10.7326/M20-6739
-
Full-Dose Anticoagulation Reduces Need for Life Support in COVID-19
(Hinzugefügt: 24.01.2021 um 09:22 Uhr)
https://www.medscape.com/viewarticle/944584
-
Full-dose blood thinners decreased need for life support and improved outcomes in hospitalized COVID-19 patients in international trial
(Hinzugefügt: 22.01.2021 um 21:43 Uhr)
https://news.umanitoba.ca/blood-thinners-decreased-need-for-life-support-and-improved-outcomes-in-hospitalized-covid-19-patients/
-
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis
(Hinzugefügt: 19.01.2021 um 12:40 Uhr)
https://www.medrxiv.org/content/10.1101/2021.01.12.21249577v1
-
Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality: a nationwide cohort study of hospitalized patients in the United State
(Hinzugefügt: 01.01.2021 um 10:51 Uhr)
https://www.medrxiv.org/content/10.1101/2020.12.09.20246579v1
-
COVID-19: US-Studie zur Behandlung mit Antikoagulanzien teilweise gestoppt
(Hinzugefügt: 28.12.2020 um 19:04 Uhr)
https://www.aerzteblatt.de/nachrichten/119714/COVID-19-US-Studie-zur-Behandlung-mit-Antikoagulanzien-teilweise-gestoppt
-
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
(Hinzugefügt: 18.12.2020 um 10:25 Uhr)
https://www.nejm.org/doi/10.1056/NEJMoa2035002
-
Association of Mortality and Aspirin Prescription for COVID-19 Patients at the Veterans Health Administration
(Hinzugefügt: 15.12.2020 um 09:38 Uhr)
https://www.medrxiv.org/content/10.1101/2020.12.13.20248147v1
-
Direct oral anticoagulant use and risk of severe COVID‐19
(Hinzugefügt: 02.12.2020 um 22:31 Uhr)
https://onlinelibrary.wiley.com/doi/10.1111/joim.13205
-
COVID-19: Direkte Antikoagulanzien schützen nicht vor schweren Verläufen
(Hinzugefügt: 02.12.2020 um 22:31 Uhr)
https://www.aerzteblatt.de/nachrichten/118973/COVID-19-Direkte-Antikoagulanzien-schuetzen-nicht-vor-schweren-Verlaeufen
-
The effect of anticoagulation on clinical outcomes in novel Coronavirus (COVID-19) pneumonia in a U.S. cohort
(Hinzugefügt: 28.11.2020 um 12:48 Uhr)
https://www.sciencedirect.com/science/article/pii/S0049384820305879?via%3Dihub
-
Healthcare disparities among anticoagulation therapies for severe COVID-19 patients
(Hinzugefügt: 11.11.2020 um 08:36 Uhr)
https://www.medrxiv.org/content/10.1101/2020.11.06.20226035v1
-
Aspirin
(Hinzugefügt: 07.11.2020 um 08:12 Uhr)
https://www.reuters.com/article/uk-health-coronavirus-recovery-aspirin-idUSKBN27M1C2
-
ASS
(Hinzugefügt: 04.11.2020 um 19:21 Uhr)
https://link.springer.com/article/10.1007/s40265-020-01365-1
-
Aspirin
(Hinzugefügt: 04.11.2020 um 11:31 Uhr)
https://journals.lww.com/anesthesia-analgesia/Abstract/9000/Aspirin_Use_is_Associated_with_Decreased.95423.aspx
-
coagulation disorders
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.sciencedirect.com/science/article/pii/S002432052031184X
-
ASS
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.n-tv.de/wissen/ASS-mildert-offenbar-Covid-19-Verlauf-article22124619.html
-
ASS
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.aerzteblatt.de/nachrichten/117689/COVID-19-Patienten-haben-mit-Low-dose-ASS-geringes-Komplikations-und-Sterberisiko
-
Studie
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://onlinelibrary.wiley.com/doi/10.1002/rmv.2180